Management of Complications of BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review

被引:0
|
作者
Khanam, Razwana [1 ]
Batool, Saba [2 ]
Najmuddin, Mohammed Musa [3 ]
Usman, Rana [4 ]
Kuriakose, Kiran [5 ]
Ahmed, Arooj [6 ]
Rehman, Mohammad Ebad Ur [7 ]
Roksana, Zinath [8 ]
Anwer, Faiz [9 ]
机构
[1] Baystate Med Ctr, Springfield, MA USA
[2] Unity Point Methodist Hosp, Peoria, IL USA
[3] Wright Ctr Grad Med Educ, Scranton, PA USA
[4] Univ Tennessee, Hlth Ctr, Memphis, TN USA
[5] UPMC Mercy, Pittsburgh, PA USA
[6] Cleveland Clin, Cleveland, OH 44106 USA
[7] Rawalpindi Med Univ, Rawalpindi, Pakistan
[8] Feni Sadar Hosp, Feni, Bangladesh
[9] Cleveland Clin, Dept Hematol & Med Oncol, Taussig Canc Inst, Cleveland, OH 44106 USA
关键词
D O I
10.1182/blood-2022-164871
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:12494 / 12495
页数:2
相关论文
共 50 条
  • [11] BCMA-directed CART therapy in patients with multiple myeloma and CNS involvement.
    Gaballa, Mahmoud R.
    Puglianini, Omar Alexis Castaneda
    Cohen, Adam D.
    Vogl, Dan T.
    Chung, Alfred
    Ferreri, Christopher J.
    Voorhees, Peter M.
    Hansen, Doris K.
    Patel, Krina K.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [12] Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma
    Liu, Yarong
    Chen, Zhi
    Fang, Hongliang
    Wei, Runhong
    Yu, Kang
    Jiang, Songfu
    Fu, Weijun
    Jiang, Hua
    Du, Juan
    He, Feng
    Xie, Ronglin
    Chen, Jing
    Wei, Baofeng
    Tao, Jin
    Wang, Pin
    BLOOD, 2018, 132
  • [13] Outcomes of Patients with Relapsed/Refractory Multiple Myeloma Who Received at Least 2 BCMA-Directed Therapies
    Snyder, Jordan
    Alsaddi, Zain
    Alkharabsheh, Omar
    Paul, Barry
    Lutfi, Forat
    Ahmed, Nausheen
    Mahmoudjafari, Zahra
    Abdallah, Al-Ola
    Atrash, Shebli
    BLOOD, 2023, 142
  • [14] Steric Hindrance By APRIL in Binding of BCMA-Directed Bispecific Antibodies: A Novel Refractory Mechanism of BCMA-Directed Immunotherapies in Multiple Myeloma
    Harada, Takeshi
    Inoue, Yusuke
    Oda, Asuka
    Teramachi, Jumpei
    Maeda, Yusaku
    Sumitani, Ryohei
    Oura, Masahiro
    Sogabe, Kimiko
    Yagi, Hikaru
    Fujii, Shiro
    Nakamura, Shingen
    Miki, Hirokazu
    Kagawa, Kumiko
    Ozaki, Shuji
    Matsuoka, Ken-ichi
    Abe, Masahiro
    BLOOD, 2024, 144 : 1884 - 1885
  • [15] BCMA after GPRC5D: Efficacy of BCMA-Directed Therapy on Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Progressing After GPRC5D-Directed Therapy
    Joiner, Laura
    Costa, Luciano
    Giri, Smith
    Ravi, Gayathri
    Godby, Kelly
    Hagedorn, Caitlin
    Bal, Susan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S61 - S62
  • [16] BCMA-Directed MRD Detection as a Predictor of Relapse after BCMA CAR T in Multiple Myeloma
    Rashid, Aliya
    Wesson, William
    Abdallah, Al-Ola
    Snyder, Jordan
    Venkatesh, Priyanka
    Mushtaq, Muhammad U.
    Shune, Leyla
    Witek, Malgorzata A.
    Mcguirk, Joseph P.
    Soper, Steven. A.
    Cui, Wei
    Ahmed, Nausheen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (01) : 52 - 57
  • [17] BCMA-directed CAR T-cell therapy in patients with multiple myeloma and CNS involvement
    Gaballa, Mahmoud R.
    Puglianini, Omar Castaneda
    Cohen, Adam
    Vogl, Dan
    Chung, Alfred
    Ferreri, Christopher J.
    Voorhees, Peter
    Hansen, Doris K.
    Patel, Krina K.
    BLOOD ADVANCES, 2025, 9 (05) : 1171 - 1180
  • [18] Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy
    Atrash, Shebli
    Mammadzadeh, Aytaj
    Peng, Fulei
    Alkharabsheh, Omar
    Afrough, Aimaz
    Cui, Wei
    Mahmoudjafari, Zahra
    Abdallah, Al-Ola
    Hashmi, Hamza
    CANCERS, 2023, 15 (11)
  • [19] Interventions and outcomes of patients with multiple myeloma receiving salvage therapy after BCMA-directed CAR T therapy
    Van Oekelen, Oliver
    Nath, Karthik
    Mouhieddine, Tarek H.
    Farzana, Tasmin
    Aleman, Adolfo
    Melnekoff, David T.
    Ghodke-Puranik, Yogita
    Shah, Gunjan L.
    Lesokhin, Alexander
    Giralt, Sergio
    Thibaud, Santiago
    Rossi, Adriana
    Rodriguez, Cesar
    Sanchez, Larysa
    Richter, Joshua
    Richard, Shambavi
    Cho, Hearn J.
    Chari, Ajai
    Usmani, Saad Z.
    Jagannath, Sundar
    Shah, Urvi A.
    Mailankody, Sham
    Parekh, Samir
    BLOOD, 2023, 141 (07) : 756 - 765
  • [20] Comprehensive Characterization of Prolonged Unexplained Cytopenias in Relapsed/Refractory Multiple Myeloma Patients Following BCMA-Directed CAR-T Cell Therapy
    Thibaud, Santiago
    Mia, Babu
    Van Oekelen, Oliver
    Mouhieddine, Tarek H.
    Schaniel, Christoph
    Ghodke-Puranik, Yogita
    Aleman, Adolfo
    Upadhyaya, Bhaskar
    Lancman, Guido
    Lagana, Alessandro
    Richard, Shambavi
    Rossi, Adriana
    Chari, Ajai
    Sanchez, Larysa
    Rodriguez, Cesar
    Cho, Hearn J.
    Richter, Joshua
    Hoffman, Ronald
    Jagannath, Sundar
    Parekh, Samir
    BLOOD, 2022, 140